Concepedia

Maki Yamashita

MY

11

Publications

287

Citations

11

H-Index

1977

Active since

Affiliations

Hirosaki University(Current)

Maki Yamashita is an author at Hirosaki University specializing in medicine, metabolic syndrome, and hypertension.

Top concepts

MedicineMetabolic SyndromeHealthDiabetesHypertensionPharmacologyEndocrinologyAdrenal DiseaseObesityUrology

Publications per year

1977–2016

11

Publications

11

Metformin restores impaired HDL-mediated cholesterol efflux due to glycation

Kota Matsuki, Naoki Tamasawa, Maki Yamashita et al. · Atherosclerosis · 2009 · 59 citations

Metabolic Syndrome, Metformin Restores, Medicine +9

HMG-CoA Reductase Inhibitor, Simvastatin Improves Reverse Cholesterol Transport in Type 2 Diabetic Patients with Hyperlipidemia

Jingzhi Guan, Naoki Tamasawa, Hiroshi Murakami et al. · Journal of Atherosclerosis and Thrombosis · 2008 · 35 citations · Full text

Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes

Hiroshi Murakami, Jutaro Tanabe, Naoki Tamasawa et al. · Diabetes Research and Clinical Practice · 2012 · 32 citations

Metabolic Syndrome, Diabetes Management, Biochemistry +7

The Frequency of Type 2 Diabetic Patients who Meet the Endocrinological Screening Criteria of Subclinical Cushing's Disease

Hiroshi Murakami, Takeshi Nigawara, Satoru Sakihara et al. · Endocrine Journal · 2010 · 27 citations · Full text

Obesity, Metabolic Syndrome, Hypertension +15

Insulin Suppresses HDL-Mediated Cholesterol Efflux from Macrophages Through Inhibition of Neutral Cholesteryl Ester Hydrolase and ATP-Binding Cassette Transporter G1 Expressions

Maki Yamashita, Naoki Tamasawa, Kota Matsuki et al. · Journal of Atherosclerosis and Thrombosis · 2010 · 25 citations · Full text

Rows per page

1–5 of 11